AI tool may forecast pancreatic cancer survival
NCT ID NCT06760234
Summary
This study tested whether an artificial intelligence (AI) model could predict how pancreatic cancer patients will fare after surgery and chemotherapy. Researchers trained the AI using pre-surgery CT scans and post-surgery tissue samples from 247 patients. The goal is to create a tool that helps doctors forecast patient prognosis and response to treatment more accurately.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
the Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.